
CELLSKIN
For Smooth Skin Regeneration


The net molding method is a groundbreaking technique for creating 3D cellular tissue. By culturing live cells inside a net, it is possible to create thick cultured skin.
After cultivation, the net is removed, leaving only the tissue consisting of cells.
It combines finely processed stainless steel mesh with a polycarbonate base.
Its simple configuration and ease of use guarantee reliable results at low cost.
Net Mold Technology
Target diseases
Large area skin defect
Congenital birthmarks and burns
Congenital birthmarks and burns require extensive skin reconstruction. Skin is made up of the epidermis on the surface and the dermis underneath, and skin regeneration requires the first regeneration of the dermis.
Currently, a small piece of the patient's own skin is cut out and attached to the affected area over the slit, but the unevenness of this slit remains when the epidermis regenerates.
CELLSKIN has a smooth surface and covers the entire affected area, which is believed to enable smoother skin regeneration.
Small area, intractable ulcer
Intractable ulcers and bedsores caused by diabetes, etc.
In diabetes, small ulcers on the toes and other areas can allow bacteria to enter, leading to amputation of fingers or feet. We believe that by closing the wounds while the ulcers are still small, it is possible to prevent or slow the progression of the condition.


Diverse applications with 3D technology
To cartilage and other organs
Net mold technology can be used with a variety of cells.
One example is cartilage regeneration using mesenchymal stem cells (MSCs).
Other potential applications include research, testing, and cell-based foods (cultured meat).
Academic papers
Development of a Self-Assembled Dermal Substitute from Human Fibroblasts Using Long-term Three-Dimensional Culture
Author: Takashi Nakano, MD, Hiroki Yamanaka, MD, PhD, Michiharu Sakamoto, MD, PhD, Itaru Tsuge, MD, PhD, Yasuhiro Katayama, MD, PhD, Susumu Saito, MD, PhD, Jiro Ono, BA, Tetsuji Yamaoka, PhD, and Naoki Morimoto, MD, PhD
Publication: Tissue Engineering Part A
Publisher: Mary Ann Liebert, Inc.
Date: Nov 1, 2023
Copyright © 2023, Mary Ann Liebert, Inc.
DOI: 10.1089/ten.tea.2023.0109
patents
Solid Portfolio

Net Mold #1
(Fundamental)

Net Mold #2
(Expansion)

Net Mold #3
(Device)
JP6256853, US10513684B2, EU3514227
JP7323966, USA-Pending, EU-Pending
JP-Pending
Grants
AMED FY2024 "Intractable Disease Practical Research Project"
Pipeline

Meet the Team
Long Term Experience. Real Technology. Real Business People.








